Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
Clinical trial NCT03533816 · RECRUITING
Trial details
- NCT number
- NCT03533816
- Sponsor
- University of Kansas Medical Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-31
- Primary completion
- 2027-01-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.